A feasibility study of microwave therapy for precancerous actinic keratosis

The results of this study conclude that a significantly higher proportion of treated AK areas responded than untreated (90% vs 15%; P < 0.001). Thin AKs were more responsive than thick AKs. The site did not affect efficacy. Pain was severe, but brief (80% reported pain lasting ‘a few seconds only’). Adverse events were minimal. All participants who would choose microwave therapy over their current treatment cited the shorter discomfort period.

For full access to the published paper, visit Wiley Online.


Transforming the way microwave energy is used in healthcare and redefining the role medical devices play in the management of complex conditions.

Find out more


Interested in using our patented platform technology for your clinical application?

Find out more


Find out more about the award-winning Swift system-delivering breakthrough treatment

Find out more

Join our team

Join our award-winning team to be working on cutting edge medical breakthroughs

Find out more